Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Circulation|November 18, 2024
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, et al.Journal of the American Heart Association|October 22, 2024
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|March 10, 2024
Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism - A Predetermined Companion Report From the ONCO PE TrialRyuki Chatani, Yugo Yamashita, Takeshi Morimoto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|December 22, 2024
Newly Diagnosed Cancer After Diagnosis of Venous Thromboembolism - Insights From the COMMAND VTE Registry-2Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, et al.Journal of the American Heart Association|September 30, 2024
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral AnticoagulantsRyusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, et al.Journal of the American Heart Association|July 31, 2024
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant EraKazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.JACC. Cardiooncology|June 17, 2026
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral AnticoagulantsTomoyuki Nagai, Naohiko Nakanishi, Yugo Yamashita, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 26, 2025
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2Tatsunori Noto, Nobutaka Ikeda, Yugo Yamashita, et al.Thrombosis and Haemostasis|April 29, 2024
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.Journal of Intensive Care|November 4, 2024
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, et al.Pageof 7